Philip Reilly

Philip Reilly

Direktör/Styrelseledamot på
Cornell University
Health Technology
Consumer Services
Finance

Profil

Phil focuses on creating and building companies that develop breakthrough therapies for orphan genetic diseases.
He is passionate about working with patient groups, and helping to unite those suffering from rare diseases in order to foster a support network and potentially improve patient outcomes.
Phil has authored or co-authored more than 100 articles in scholarly journals and has published seven books including most recently Orphan: The Quest to Save Children with Rare Genetic Disorders.
Phil currently serves on the Advisory Board to the Boston University School of Public Health, and has served as a trustee emeritus of Cornell University, an Overseer of Weill Cornell Medical College.

Aktiva positioner av Philip Reilly

FöretagPositionStart
Direktör/Styrelseledamot 2010-06-03
Direktör/Styrelseledamot -
Direktör/Styrelseledamot -

Tidigare kända positioner av Philip Reilly

FöretagPositionSlut
Direktör/Styrelseledamot 2016-12-31
INTERLEUKIN GENETICS, INC Ordförande -
VOYAGER THERAPEUTICS, INC. Teknisk/Vetenskaplig/F&U Direktör -
Grundare -
GENETIX BIOTHERAPEUTICS, INC. Teknisk/Vetenskaplig/F&U Direktör -
Se detaljerna i Philip Reillys erfarenhet

Philip Reillys utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

88

Första gradens relationer

14

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag14

Health Technology

Consumer Services

Health Technology

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Finance

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

  1. Börsen
  2. Insiders
  3. Philip Reilly